Open AccessA novel use of cardiac resynchronization therapy‐defibrillator device in hypertrophic cardiomyopathy
Author(s) -
Cay Serkan,
Ozeke Ozcan,
Ozcan Firat,
Aras Dursun,
Topaloglu Serkan
Publication year - 2019
Publication title -
annals of noninvasive electrocardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 48
eISSN - 1542-474X
pISSN - 1082-720X
DOI - 10.1111/anec.12559
Subject(s) - medicine , cardiology , cardiac resynchronization therapy , ejection fraction , hypertrophic cardiomyopathy , implantable cardioverter defibrillator , atrioventricular block , cardiomyopathy , sudden cardiac death , heart failure
Dual‐chamber implantable cardioverter‐defibrillator is generally used in patients with atrioventricular block and hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. In the current case, a cardiac resynchronization therapy‐defibrillator device was implanted in a patient with non‐obstructive hypertrophic cardiomyopathy with preserved ejection fraction and atrioventricular block to achieve both more physiological pacing and life‐threatening ventricular arrhythmia management.